Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Trajectories of glomerular filtration rate and rogression to end stage kidney disease after kidney transplantation (CROSBI ID 320427)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Raynaud, Marc ; Aubert, Olivier ; Reese, Peter P. ; Bouatou, Yassine ; Naesens, Maarten ; Kamar, Nassim ; Bailly, Élodie ; Giral, Magali ; Ladrière, Marc ; Le Quintrec, Moglie et al. Trajectories of glomerular filtration rate and rogression to end stage kidney disease after kidney transplantation // Kidney international, 99 (2021), 1; 186-197. doi: 10.1016/j.kint.2020.07.025

Podaci o odgovornosti

Raynaud, Marc ; Aubert, Olivier ; Reese, Peter P. ; Bouatou, Yassine ; Naesens, Maarten ; Kamar, Nassim ; Bailly, Élodie ; Giral, Magali ; Ladrière, Marc ; Le Quintrec, Moglie ; Delahousse, Michel ; Jurić, Ivana ; Bašić-Jukić, Nikolina ; Gupta, Gaurav ; Akalin, Enver ; Yoo, Daniel ; Chin, Chen- Shan ; Proust-Lima, Cécile ; Böhmig, Georg ; Oberbauer, Rainer ; Stegall, Mark D. ; Bentall, Andrew J. ; Jordan, Stanley C. ; Huang, Edmund ; Glotz, Denis ; Legendre, Christophe ; Montgomery, Robert A. ; Segev, Dorry L. ; Empana, Jean-Philippe ; Grams, Morgan E. ; Coresh, Josef ; Jouven, Xavier ; Lefaucheur, Carmen ; Loupy, Alexandre

engleski

Trajectories of glomerular filtration rate and rogression to end stage kidney disease after kidney transplantation

Although the gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR), little is known about GFR trajectories after transplantation, their determinants, and their association with outcomes. To evaluate these parameters we examined kidney transplant recipients receiving care at 15 academic centers. Patients underwent prospective monitoring of estimated GFR (eGFR) measurements, with assessment of clinical, functional, histological and immunological parameters. Additional validation took place in seven randomized controlled trials that included a total of 14, 132 patients with 403, 497 eGFR measurements. After a median follow-up of 6.5 years, 1, 688 patients developed end-stage kidney disease. Using unsupervised latent class mixed models, we identified eight distinct eGFR trajectories. Multinomial regression models identified seven significant determinants of eGFR trajectories including donor age, eGFR, proteinuria, and several significant histological features: graft scarring, graft interstitial inflammation and tubulitis, microcirculation inflammation, and circulating anti-HLA donor specific antibodies. The eGFR trajectories were associated with progression to end stage kidney disease. These trajectories, their determinants and respective associations with end stage kidney disease were similar across cohorts, as well as in diverse clinical scenarios, therapeutic eras and in the seven randomized control trials. Thus, our results provide the basis for a trajectory-based assessment of kidney transplant patients for risk stratification and monitoring.

GFR ; ESRD ; kidney transplantation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

99 (1)

2021.

186-197

objavljeno

0085-2538

1523-1755

10.1016/j.kint.2020.07.025

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost